keyword
https://read.qxmd.com/read/38440953/novel-automated-antifungal-susceptibility-testing-system-for-yeasts-based-on-dual-detection-algorithm-of-turbidimetry-and-colorimetry
#21
JOURNAL ARTICLE
Tingting Shen, Piao Liu, Dongmiao Chen, Duoduo Liu, Juan Fang, Qian Wang, Yinjuan Xu, Chunjuan Tan, Congrong Wang
Introduction. The increasing prevalence and growing resistance of fungi present a significant peril to public health. There are only four classes of antifungal medicines available today, and few candidates are in clinical trials. Hypothesis/Gap Statement. Rapid and sensitive diagnostic techniques are lacking for most fungal pathogens, and those that do exist are expensive or hard to obtain. Aim. This study aimed to evaluate the feasibility of a novel automated antifungal susceptibility testing system, Fungus AST, in comparison to the broth microdilution method (BMD) recommended by the Clinical and Laboratory Standards Institute (CLSI)...
March 2024: Journal of Medical Microbiology
https://read.qxmd.com/read/38415653/a-novel-lentiviral-vector-based-approach-to-generate-chimeric-antigen-receptor-t-cells-targeting-aspergillus-fumigatus
#22
JOURNAL ARTICLE
Pappanaicken R Kumaresan, Sebastian Wurster, Karishma Bavisi, Thiago Aparecido da Silva, Paul Hauser, Jordan Kinnitt, Nathaniel D Albert, Uddalak Bharadwaj, Sattva Neelapu, Dimitrios P Kontoyiannis
Invasive aspergillosis (IA) is a common and deadly mold infection in immunocompromised patients. As morbidity and mortality of IA are primarily driven by poor immune defense, adjunct immunotherapies, such as chimeric antigen receptor (CAR) T cells, are direly needed. Here, we propose a novel approach to generate Aspergillus fumigatus (AF)-CAR T cells using the single-chain variable fragment domain of monoclonal antibody AF-269-5 and a lentiviral vector system. These cells successfully targeted mature hyphal filaments of representative clinical and reference AF isolates and elicited a potent release of cytotoxic effectors and type 1 T cell cytokines...
February 28, 2024: MBio
https://read.qxmd.com/read/38361958/-candida-glabrata-oropharyngeal-infection-in-a-patient-with-oral-squamous-cell-carcinoma-after-covid-19-infection
#23
Jalal Jafarzadeh, Javad Javidnia, Seyed Ali Jeddi, Mahshid Vakili, Mojtaba Taghizadeh Armaki, Mahin Tavakoli
BACKGROUND AND PURPOSE: The COVID-19 pandemic may be an aggravating risk factor for the delay of the diagnoses of serious illnesses, such as oral squamous cell carcinoma, as well as poor management of patients with underlying morbidities, the onset of oral lesions, and antifungal susceptibility to opportunistic fungal infections. Oral candidiasis is one of the most common oral features of COVID-19. CASE REPORT: This study aimed to report an 83-year-old female diagnosed with oral carcinoma who developed oropharyngeal candidiasis after falling ill with COVID-19...
September 2023: Current Medical Mycology
https://read.qxmd.com/read/38327878/a-rare-case-of-scedosporium-apiospermum-osteomyelitis-in-an-immunocompetent-patient
#24
Aayushi J Rajani, Darshankumar Raval, Rohit Chitale, Ravindra Durvasula, Justin Oring, Ross Powers
Scedosporium, a widespread filamentous fungus found in diverse environments, has experienced a rise in cases due to escalating malignancies and chronic immunosuppression. Clinical manifestations span mycetoma, airway involvement, and various infections, with osteomyelitis being a notable complication. We present a case of a 77-year-old female initially displaying cutaneous Scedosporium signs, which progressed to osteomyelitis. The patient, with a history of trauma, chronic low dose steroid use, and underlying conditions, presented with a foot injury caused by her dog...
2024: IDCases
https://read.qxmd.com/read/38306882/sar-study-of-n-salicylidene-heteroarenecarbohydrazides-as-promising-antifungal-agents
#25
JOURNAL ARTICLE
Yi Sun, Saerom Kim, SeungYoun Shin, Kathryn Takemura, Gabriel S Matos, Cristina Lazzarini, Krupanandan Haranahalli, Julia Zambito, Ashna Garg, Maurizio Del Poeta, Iwao Ojima
Clinically available antifungal drugs have therapeutic limitations due to toxicity, narrow spectrum of activity, and intrinsic or acquired drug resistance. Thus, there is an urgent need for new broad-spectrum antifungal agents with low toxicity and a novel mechanism of action. In this context, we have successfully identified several highly promising lead compounds, i.e., aromatic N'-(salicylidene)carbohydrazides, exhibiting excellent antifungal activities against Cryptococcus neoformans, Candida albicans, Aspergillus fumigatus and several other fungi both in vitro and in vivo...
January 24, 2024: Bioorganic & Medicinal Chemistry
https://read.qxmd.com/read/38297200/a-regimen-based-on-the-combination-of-trimethoprim-sulfamethoxazole-with-caspofungin-and-corticosteroids-as-a-first-line-therapy-for-patients-with-severe-non-hiv-related-pneumocystis-jirovecii-pneumonia-a-retrospective-study-in-a-tertiary-hospital
#26
JOURNAL ARTICLE
Hao Li, Yihe Lu, Guoxin Tian, Yongxing Wu, Tianjun Chen, Jiangwei Zhang, Nan Hu, Xiaoning Wang, Yang Wang, Lan Gao, Jinqi Yan, Linjing Zhou, Qindong Shi
BACKGROUND: Pneumocystis jirovecii pneumonia (PJP) is a life-threatening and severe disease in immunocompromised hosts. A synergistic regimen based on the combination of sulfamethoxazole-trimethoprim (SMX-TMP) with caspofungin and glucocorticosteroids (GCSs) may be a potential first-line therapy for PJP. Therefore, it is important to explore the efficacy and safety of this synergistic therapy for treating non-HIV-related PJP patients. METHODS: We retrospectively analysed the data of 38 patients with non-HIV-related PJP at the First Affiliated Hospital of Xi'an Jiaotong University...
January 31, 2024: BMC Infectious Diseases
https://read.qxmd.com/read/38276031/associations-between-genomic-variants-and-antifungal-susceptibilities-in-the-archived-global-candida-auris-population
#27
JOURNAL ARTICLE
Yue Wang, Jianping Xu
Candida auris is a recently emerged human fungal pathogen that has posed a significant threat to public health. Since its first identification in 2009, this fungus has caused nosocomial infections in over 47 countries across all inhabited continents. As of May 2023, the whole-genome sequences of over 4000 strains have been reported and a diversity of mutations, including in genes known to be associated with drug resistance in other human fungal pathogens, have been described. Among them, 387 strains contained antifungal-susceptibility information for which different methods might be used depending on the drugs and/or investigators...
January 22, 2024: Journal of Fungi (Basel, Switzerland)
https://read.qxmd.com/read/38265608/safety-and-efficacy-of-non-reduced-use-of-caspofungin-in-patients-with-child-pugh-b-or-c-cirrhosis-a-real-world-study
#28
JOURNAL ARTICLE
Shi-Dan Yuan, Ke-Li Wen, Yun-Xing Cao, Wen-Qi Huang, An Zhang
BACKGROUND AND PURPOSE: The need for dose adjustment of caspofungin in patients with hepatic impairment is controversial, especially for those with Child-Pugh B or C cirrhosis. The purpose of this study was to investigate the safety and efficacy of standard-dose caspofungin administration in Child-Pugh B and C cirrhotic patients in a real-world clinical setting. PATIENTS AND METHODS: The electronic medical records of 258 cirrhotic patients, including 67 Child-Pugh B patients and 191 Child-Pugh C patients, who were treated with standard-dose of caspofungin at the Second Affiliated Hospital of Chongqing Medical University, China, from March 2018 to June 2023 were reviewed retrospectively...
January 24, 2024: Infection
https://read.qxmd.com/read/38253205/development-of-an-environmentally-sensitive-fluorescent-peptide-probe-for-mrgx2-and-application-in-ligand-screening-of-peptide-antibiotics
#29
JOURNAL ARTICLE
Yajing Hou, Jiayu Lu, Mengyao Yi, Xia Cui, Lu Cao, Xianpeng Shi, Pengchong Wang, Nan Zhou, Peng Zhang, Cheng Wang, Huaizhen He, Delu Che
Mast cells (MCs) are primary effector cells involved in immediate allergic reactions. Mas-related G protein-coupled receptor-X2 (MrgX2), which is highly expressed on MCs, is involved in receptor-mediated drug-induced pseudo-anaphylaxis. Many small-molecule drugs and peptides activate MrgX2, resulting in MC activation and allergic reactions. Although small-molecule drugs can be identified using existing MrgX2 ligand-screening systems, there is still a lack of effective means to screen peptide ligands. In this study, to screen for peptide drugs, the MrgX2 high-affinity endogenous peptide ligand substance P (SP) was used as a recognition group to design a fluorescent peptide probe...
January 20, 2024: Journal of Controlled Release
https://read.qxmd.com/read/38252052/18s-rrna-sequencing-and-homology-analysis-of-post-traumatic-bloodstream-infection-with-saprochaete-clavata-magnusiomyces-clavatus-and-a-case-report
#30
JOURNAL ARTICLE
Wei Jia, Guang Chen, Wanxiang Li, Jie Ma, Xue Zhao
We present a case of bloodstream infection with Saprochaete clavata following an abdominal steel impact injury in a 52-year-old man, whose non-healing abdominal wound was also highly suspected of being caused by Saprochaete clavata. Saprochaete clavata is a very uncommon fungal pathogen. Our case is distinctive in that previous reports have typically involved immunocompromised, malignant, or leukemic patients. In contrast, our case involved a middle-aged man in good health who had ileal perforation repair for gastrointestinal perforation...
January 2024: New Microbiologica
https://read.qxmd.com/read/38238874/-candida-auris-associated-hospitalizations-and-outbreaks-china-2018-2023
#31
JOURNAL ARTICLE
Jian Bing, Han Du, Penghao Guo, Tianren Hu, Meng Xiao, Sha Lu, Clarissa J Nobile, Haiqing Chu, Guanghua Huang
The emerging human fungal pathogen Candida auris has become a serious threat to public health. This pathogen has spread to 10 provinces in China as of December 2023. Here we describe 312 C. auris -associated hospitalizations and 4 outbreaks in healthcare settings in China from 2018 to 2023. Three genetic clades of C. auris have been identified during this period. Molecular epidemiological analyses indicate that C. auris has been introduced and local transmission has occurred in multiple instances in China. Most C...
December 2024: Emerging Microbes & Infections
https://read.qxmd.com/read/38232343/species-distribution-and-antifungal-susceptibility-profiles-of-clinical-and-environmental-fusarium-isolates-from-mexico-a-multicenter-study
#32
MULTICENTER STUDY
Alexandra M Montoya, Joan E Rodríguez-Grimaldo, Luis Esaú López-Jácome, Alexandro Bonifaz, Erika Enríquez-Domínguez, Laura R Castañón-Olivares, Claudia Lisette Charles-Niño, Armando Rodríguez-Rodríguez, Rogelio de J Treviño-Rangel, Olga C Rojas, Gloria M González
Fusarium spp. has emerged as an opportunistic etiological agent with clinical manifestations varying from localized infections to deep-seated systemic disease. It is also a phytopathogen of economic impact. There are few reports on the species diversity of this genus, and no comprehensive studies on the epidemiology nor the antifungal susceptibility of Fusarium in Mexico. The present multicentric study aims to shed light on the species distribution and antifungal susceptibility patterns of 116 strains of Fusarium isolated from clinical and environmental samples...
2024: Mycologia
https://read.qxmd.com/read/38169568/development-of-a-yeast-cell-based-method-for-efficient-screening-of-high-yield-tacrolimus-production-strain
#33
JOURNAL ARTICLE
Yu-Ke Cen, Nai-Ying He, Wan-Ying Zhou, Zhi-Qiang Liu, Yu-Guo Zheng
UNLABELLED: Tacrolimus (FK506) is a widely used and clinically important immunosuppressant drug that can be produced by fermentation of Streptomyces tsukubaensis . The industrial strains are typically obtained through multiple rounds of mutagenesis and screening, a labor-intensive process. We have established an efficient yeast cell based screening method for the evolutionary process of high-FK506-yielding strain. The S. tsukubaensis strains of different FK506 yields were tested for zone of growth inhibition of the wild type and calcineurin mutant ( cnb1∆ ) yeast strains...
January 2024: 3 Biotech
https://read.qxmd.com/read/38165721/mimicking-charged-host-defense-peptides-to-tune-the-antifungal-activity-and-biocompatibility-of-amphiphilic-polymers
#34
JOURNAL ARTICLE
Sebastian Schaefer, Daniele Melodia, Christopher Pracey, Nathaniel Corrigan, Megan D Lenardon, Cyrille Boyer
Invasive fungal infections impose a substantial global health burden. They cause more than 1.5 million deaths annually and are insufficiently met by the currently approved antifungal drugs. Antifungal peptides are a promising alternative to existing antifungal drugs; however, they can be challenging to synthesize, and are often susceptible to proteases in vivo . Synthetic polymers which mimic the properties of natural antifungal peptides can circumvent these limitations. In this study, we developed a library of 29 amphiphilic polyacrylamides with different charged units, namely, amines, guanidinium, imidazole, and carboxylic acid groups, representative of the natural amino acids lysine, arginine, histidine, and glutamic acid...
January 2, 2024: Biomacromolecules
https://read.qxmd.com/read/38161046/the-impact-of-extracorporeal-membrane-oxygenation-on-antifungal-pharmacokinetics-a-systematic-review
#35
REVIEW
Ali Jendoubi, Claire Pressiat, Quentin De Roux, Anne Hulin, Bijan Ghaleh, Renaud Tissier, Matthias Kohlhauer, Nicolas Mongardon
BACKGROUND AND OBJECTIVE: The use of extracorporeal membrane oxygenation (ECMO) as a cardiocirculatory or respiratory support has tremendously increased in critically ill patients. In the setting of ECMO support, invasive fungal infections are a severe cause of morbidity and mortality. This vulnerable population is at risk of suboptimal antifungal exposure due to an increased volume of distribution (Vd), drug sequestration and decreased clearance. Here, we aimed to summarize ex-vivo and clinical studies on the potential impact of ECMO on the pharmacokinetics (PK) of antifungal agents and dosing requirements...
December 29, 2023: International Journal of Antimicrobial Agents
https://read.qxmd.com/read/38156315/culture-media-influences-candida-parapsilosis-growth-susceptibility-and-virulence
#36
JOURNAL ARTICLE
Betsy V Arévalo-Jaimes, Joana Admella, Núria Blanco-Cabra, Eduard Torrents
INTRODUCTION: Candida parapsilosis , a pathogenic yeast associated with systemic infections, exhibits metabolic adaptability in response to nutrient availability. METHODS: We investigated the impact of RPMI glucose supplemented (RPMId), TSB, BHI and YPD media on C. parapsilosis growth, morphology, susceptibility (caspofungin and amphotericin B), and in vivo virulence ( Galleria mellonella ) in planktonic and biofilm states. RESULTS: High-glucose media favors growth but hinders metabolic activity and filamentation...
2023: Frontiers in Cellular and Infection Microbiology
https://read.qxmd.com/read/38125361/hospital%C3%A2-acquired-pneumonia-caused-by-kodamaea%C3%A2-ohmeri-during-extracorporeal-membrane-oxygenation-treatment-a-case-report-and-literature-review
#37
Tao Ding, Yi Zhu, Zhong-Man Zhang, Yue Zou, Di An, Wei Li, Xu-Feng Chen
Kodamaea ohmeri ( K. ohmeri ) is an ascosporogenic species of yeast that belongs to the genus Ascosporogenous and the family of Saccharomycetaceae. It has recently been found to cause various types of infections, particularly in critically ill immunocompromised patients. The present study describes a case of hospital-acquired pneumonia caused by K. ohmeri during veno-arterial extracorporeal membrane oxygenation. The fungal culture turned negative after the administration of caspofungin and amphotericin B. Extracorporeal membrane oxygenation (ECMO) is an adjunctive medical technique that provides temporary cardiopulmonary support for patients...
January 2024: Experimental and Therapeutic Medicine
https://read.qxmd.com/read/38097319/derivative-of-7-hydroxycoumarin-has-antifungal-potential-against-candida-species-and-low-cytotoxicity-against-human-cells-in-silico-studies-and-biological-evaluation
#38
JOURNAL ARTICLE
Paula Lima Nogueira, Danielle da Nóbrega Alves, Palloma Christine Queiroga Gomes da Costa, Gleycyelly Rodrigues Araujo, Alana Rodrigues Ferreira, Ana Paula Gomes Moura Farias, Natália Ferreira de Sousa, Marianna Vieira Sobral, Damião Pergentino de Sousa, Marcus Tullius Scotti, Luciana Scotti, Ricardo Dias de Castro
This study investigates the antifungal and cytotoxic properties of 7-(pentyloxy)-2H-chromen-2-one. Through molecular docking and dynamics simulations, we explored the compound's interactions with fungal cell protein targets. Notably, it exhibited strong affinities for 1,3β-glucan synthase, squalene epoxidase, δ-14-sterol reductase, 14-α-demethylase, and thymidylate synthase, with binding energies ranging from -100.39 to -73.15 kcal/mol. Molecular dynamics simulations confirmed its stable binding at active targets...
December 2023: Fungal Biology
https://read.qxmd.com/read/38092335/invasive-fungal-infection-caused-by-blastobotrys-mokoenaii-in-an-immunocompromised-patient-with-acute-myeloid-leukemia-a-case-report
#39
Ichiro Shiomi, Yosuke Makuuchi, Ikue Noura, Shigeki Kakuno, Makoto Niki, Yuto Kaimi, Kentaro Ido, Kazuki Sakatoku, Masatomo Kuno, Teruhito Takakuwa, Hiroshi Okamura, Mitsutaka Nishimoto, Yasuhiro Nakashima, Mika Nakamae, Hiroshi Kakeya, Kenichi Kohashi, Masayuki Hino, Hirohisa Nakamae
Blastobotrys is a genus of rare yeast that is increasingly recognized as a cause of fungal infections in humans. However, there have been no reports of fungal infections in humans caused by Blastobotrys mokoenaii. We describe a case of invasive fungal infection (IFI) caused by B. mokoenaii in an immunocompromised patient with acute myeloid leukemia (AML). A 46-year-old man with relapsed/refractory AML underwent a second allogeneic peripheral blood hematopoietic stem cell transplantation (allo-PBSCT) during remission...
December 11, 2023: Journal of Infection and Chemotherapy: Official Journal of the Japan Society of Chemotherapy
https://read.qxmd.com/read/38076460/implications-of-empirical-administration-of-caspofungin-in-covid-19-complicated-fungal-infections
#40
JOURNAL ARTICLE
Kazuhiro Itoh, Hiroshi Tsutani, Yasuhiko Mitsuke, Hiromichi Iwasaki
No abstract text is available yet for this article.
2023: Frontiers in Cellular and Infection Microbiology
keyword
keyword
54692
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.